BSEBoard Meeting21 Oct 2026 · 21 Oct 2026, 01:47 pm

Zenith Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve Intimation of Board Meeting to be held on Wednesday, October 28, 2026 -Unaudited Result for the quarter and half year ended 30.09.2026.

Zenith Healthcare Ltd · 530665

✦ AI SummaryResults

Zenith Healthcare Ltd has scheduled a Board Meeting on October 28, 2026, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Zenith Healthcare Ltd - 530665 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, October 28, 2026

Attachments (1)

📄

4b36f5d9-5a2d-493a-9442-a70496f05e5b.pdf

pdf

Download →
View document text
Ref. No. : ZHL/Notice/2026-27/005 Date: 21st October, 2026 BSE Ltd. Floor 25, P. J. Towers Dalal Street, Mumbai - 400 001 Dear Sir, Sub: - Intimation of Board Meeting to be held on Wednesday, October 28, 2026 BSE Code: 530665 This is to inform you under Regulation 29 and any other Regulation of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, a Meeting of the Board of Directors of the Company will be held on Wednesday, 28th October, 2026 at the Registered Office of the Company at 504, Iscon Elegance, Nr. Ananddham Jain Derasar, Prahladnagar Cross Road, S.G. Road, Ahmedabad – 380 015 to transact following business; 1. To consider and approve the unaudited financial results of the Company for the quarter and half year ended on 30th September, 2026. 2. Any other matter with the permission of the Chair. We further wish to inform that in terms of SEBI (Prohibition of Insider Trading) Regulations, and Code of Conduct for Prevention of Insider Trading of the Company, the Trading Window for dealing in securities of the Company which had been closed earlier, shall remain closed till 48 hours after the declaration of financial results for the quarter and half year ended on September 30, 2026. You are requested to take the same on your record. Thanking you, Yours faithfully, For, Zenith Healthcare Limited (Mihir S. Shah) Company Secretary & Compliance Officer ACS No. 41922